{
    "2019-12-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Lilly Initiates Phase III Lung Cancer Study on RET Inhibitor",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Phase III",
                        "Lung Cancer",
                        "RET Inhibitor"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-20",
                "original_text": "Big Pharma’s Coming Back in 2020. Don’t Hold Your Breath for Generic Drug Stocks",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "Generic Drug Stocks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}